Lipoxamycin is an antifungal antibiotic and a potent inhibitor of serine palmitoyltransferase (IC50 = 21 nM); it exhibits antifungal activity against a panel of human pathogenic fungi, with higher potency against certain Candida species (MIC values: 0.25–16 µg/mL), and shows the greatest sensitivity in Cryptococcus neoformans; it also demonstrates activity against filamentous fungi in disk diffusion assays and exhibits potent inhibitory activity against the mammalian serine palmitoyltransferase enzyme.